Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Review of Anticancer Therapy
List of Issues
Volume 20, Issue 5

Expert Review of Anticancer Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Review of Anticancer Therapy, Volume 20, Issue 5 (2020)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 20, Issue 5 (2020)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Volume 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Dario Trapani & Giuseppe Curigliano

Pages: 325-328

Published online: 28 Apr 2020

First Page PreviewforHow can biosimilars change the trajectory of breast cancer therapy? | Full Text | References | PDF (555.1 KB) | EPUB

1544 Views
11 CrossRef citations
0Altmetric

Free Access

Editorial

Addressing the controversial role of ketogenic diets in cancer treatment

Rainer Johannes Klement

Pages: 329-332

Published online: 29 Mar 2020

First Page PreviewforAddressing the controversial role of ketogenic diets in cancer treatment | Full Text | References | PDF (488.5 KB) | EPUB

3882 Views
2 CrossRef citations
0Altmetric

Free Access

Drug Profile

Article

Entrectinib for the treatment of metastatic NSCLC: safety and efficacy

Andrea Sartore-Bianchi, Elio Gregory Pizzutilo, Giovanna Marrapese, Federica Tosi, Giulio Cerea & Salvatore Siena

Pages: 333-341

Published online: 08 Apr 2020

AbstractforEntrectinib for the treatment of metastatic NSCLC: safety and efficacy | Full Text | References | PDF (1.3 MB) | EPUB

856 Views
21 CrossRef citations
0Altmetric

Article

Avelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacy

Isla Leslie, Laura Amanda Boos, James Larkin & Lisa Pickering

Pages: 343-354

Published online: 07 May 2020

AbstractforAvelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacy | Full Text | References | PDF (914.2 KB) | EPUB

507 Views
0 CrossRef citations
0Altmetric

Review

Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development

Michael Ruff, Sani Kizilbash & Jan Buckner

Pages: 355-363

Published online: 12 May 2020

AbstractforFurther understanding of glioma mechanisms of pathogenesis: implications for therapeutic development | Full Text | References | PDF (713.7 KB) | EPUB

576 Views
10 CrossRef citations
0Altmetric

Review

EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy

Pauline Hulo, Dahna Coupez, Marc G Denis & Jaafar Bennouna

Pages: 365-372

Published online: 26 Apr 2020

AbstractforEGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy | Full Text | References | PDF (850 KB) | EPUB

515 Views
6 CrossRef citations
0Altmetric

Review

microRNAs as biomarkers of ovarian cancer

Huilin Zhang & Bingjian Lu

Pages: 373-385

Published online: 03 May 2020

AbstractformicroRNAs as biomarkers of ovarian cancer | Full Text | References | PDF (1.3 MB) | EPUB

653 Views
12 CrossRef citations
0Altmetric

Review

Current radiotherapy techniques in NSCLC: challenges and potential solutions

Niccolò Giaj-Levra, Paolo Borghetti, Alessio Bruni, Patrizia Ciammella, Francesco Cuccia, Alessandra Fozza, Davide Franceschini, Vieri Scotti, Stefano Vagge & Filippo Alongi

Pages: 387-402

Published online: 13 May 2020

AbstractforCurrent radiotherapy techniques in NSCLC: challenges and potential solutions | Full Text | References | PDF (1.1 MB) | EPUB

659 Views
21 CrossRef citations
0Altmetric

Review

Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma

Francesco Spagnolo, Elena Croce, Andrea Boutros, Enrica Tanda, Federica Cecchi, Matteo Mascherini, Nicola Solari, Ferdinando Cafiero & Paola Queirolo

Pages: 403-413

Published online: 03 May 2020

AbstractforNeoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma | Full Text | References | PDF (932.1 KB) | EPUB

255 Views
2 CrossRef citations
0Altmetric

Review

What is the best clinical approach to recurrent/refractory osteosarcoma?

Cristina Meazza, Stefano Bastoni & Paolo Scanagatta

Pages: 415-428

Published online: 07 May 2020

AbstractforWhat is the best clinical approach to recurrent/refractory osteosarcoma? | Full Text | References | PDF (1.3 MB) | EPUB

496 Views
18 CrossRef citations
0Altmetric

Correction

Page: i

Published online: 05 May 2020

CitationforCorrection | Full Text | PDF (51.3 KB) | EPUB

373 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Treatment options in the advanced and recurrent setting for endometrial cancer: an update

Alex Andrea Francoeur et al.

Review Article | Published online: 18 Jun 2024

Nomogram and calculator for predicting the prognosis of patients with giant hepatocellular carcinoma

Wanjin Chen et al.

Article | Published online: 17 Jun 2024

The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis

Chiara Ciccarese et al.

Review Article | Published online: 16 Jun 2024

Open Access

Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer

Renata Pacholczak-Madej et al.

Review Article | Published online: 14 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Anticancer Therapy (Vol.20, Iss.5, 2020)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?